5th International Symposium on Focused Ultrasound : North Bethesda, MD, USA. 28 August- 1 September 2016

PSA was reduced from median PSAtr (6.45) to a median Nadir of 1.45 ng/ml within median 12.5 weeks and showed a trend to relapse with a post-HIFU PSA velocity Conclusions Focal HIFU - a non invasive single session therapy performed under spinal anesthesia - demonstrated high potency- and continence preservation while treating diagnosed prostate cancer lesions.

also in 53,322 other papers